Advanced in Primitive Neuroectodermal Tumor (PNET)

Dr. Lars Anker

Neurosurgery | Oncology
101 East Valencia Mesa Drive, 
Fullerton, CA 
Accepting New Patients
Advanced in Primitive Neuroectodermal Tumor (PNET)
101 East Valencia Mesa Drive, 
Fullerton, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Lars Anker is an Oncologist and a Neurosurgery provider in Fullerton, California. Dr. Anker is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Subdural Hematoma, Apoplexy, Stroke, Awake Craniotomy, and Gastrostomy. Dr. Anker is currently accepting new patients.

His clinical research consists of co-authoring 1 peer reviewed article and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Neurosurgery
Oncology
Licenses
Neurological Surgery in CA
Hospital Affiliations
Providence St. Joseph Hospital
Providence St. Jude Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

101 East Valencia Mesa Drive, Fullerton, CA 92835

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

EF-32: Pivotal, Randomized, Open-Label Study of Optune® (Tumor Treating Fields, 200kHz) Concomitant With Radiation Therapy and Temozolomide for the Treatment of Newly Diagnosed Glioblastoma
EF-32: Pivotal, Randomized, Open-Label Study of Optune® (Tumor Treating Fields, 200kHz) Concomitant With Radiation Therapy and Temozolomide for the Treatment of Newly Diagnosed Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: August 07, 2025
Intervention Type: Device
Study Phase: Not Applicable
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).
Enrollment Status: Completed
Publish Date: January 28, 2025
Intervention Type: Device, Other
Study Phase: Phase 3
A Phase 3 Multicenter Study of Gleolan (Aminolevulinic Acid Hydrochloride) to Enhance Visualization of Tumor in Patients With Newly Diagnosed or Recurrent Meningiomas
A Phase 3 Multicenter Study of Gleolan (Aminolevulinic Acid Hydrochloride) to Enhance Visualization of Tumor in Patients With Newly Diagnosed or Recurrent Meningiomas
Enrollment Status: Completed
Publish Date: June 18, 2024
Intervention Type: Drug
Study Drug: Gleolan
Study Phase: Phase 3
A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC Versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma
A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC Versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma
Enrollment Status: Terminated
Publish Date: February 07, 2020
Intervention Type: Biological, Drug
Study Phase: Phase 2/Phase 3
A Phase 3, Randomized, Controlled, Double-Arm, Open-Label, Multi-center Study of VB-111 Combined With Bevacizumab vs. Bevacizumab Monotherapy in Patients With Recurrent Glioblastoma
A Phase 3, Randomized, Controlled, Double-Arm, Open-Label, Multi-center Study of VB-111 Combined With Bevacizumab vs. Bevacizumab Monotherapy in Patients With Recurrent Glioblastoma
Enrollment Status: Completed
Publish Date: October 23, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

1 Total Publications

Pilot Study of High-Dose Pemetrexed in Patients with Progressive Chordoma.
Pilot Study of High-Dose Pemetrexed in Patients with Progressive Chordoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 18, 2023
Similar Doctors
Distinguished in Primitive Neuroectodermal Tumor (PNET)
Dr. Christopher M. Duma
Neurosurgery
Distinguished in Primitive Neuroectodermal Tumor (PNET)
Dr. Christopher M. Duma
Neurosurgery

Brain And Spine Surgeons Of Orange County A Medical Corporation

3900 W Coast Hwy, Suite 300, 
Newport Beach, CA 
 (18.8 miles away)
949-642-6787
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Christopher Duma is a Neurosurgery provider in Newport Beach, California. Dr. Duma is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Astrocytoma, Glioblastoma, Glioma, Awake Craniotomy, and Deep Brain Stimulation.

Distinguished in Primitive Neuroectodermal Tumor (PNET)
Dr. William G. Loudon
Neurosurgery | General Surgery
Distinguished in Primitive Neuroectodermal Tumor (PNET)
Dr. William G. Loudon
Neurosurgery | General Surgery
101 East Valencia Mesa Drive, 
Fullerton, CA 
 (0.1 miles away)
714-734-3280
Languages Spoken:
English
See accepted insurances
Accepting New Patients

William Loudon is a General Surgeon and a Neurosurgery provider in Fullerton, California. Dr. Loudon is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Bulging Fontanelles, Primitive Neuroectodermal Tumor (PNET), Hydrocephalus, and Sunken Fontanelles. Dr. Loudon is currently accepting new patients.

Distinguished in Primitive Neuroectodermal Tumor (PNET)
Dr. Behnam B. Badie
Neurosurgery
Distinguished in Primitive Neuroectodermal Tumor (PNET)
Dr. Behnam B. Badie
Neurosurgery

City Of Hope Medical Foundation

1500 E Duarte Rd, 
Duarte, CA 
 (16.4 miles away)
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Behnam Badie is a Neurosurgery provider in Duarte, California. Dr. Badie is rated as an Elite provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Glioma, Glioblastoma, Astrocytoma, Awake Craniotomy, and Gastrostomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Anker's expertise for a condition
ConditionClose
    View All 21 Advanced Conditions
    View All 39 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile